Takeda's Adzynma approved for prophylactic and on-demand treatment of cTTP 07-Dec-2023 By Liza Laws Adults and children in the US with congenital thrombotic thrombocytopenic purpura (cTTP) can now access Adzynma for prophylactic and on-demand treatment.